Infants can experience pain similar to adults, and improperly controlled pain stimuli could have a long-term adverse impact on their cognitive and neurological function development.
The biggest challenge of achieving good infant pain control is obtaining objective pain assessment when direct communication is lacking. For years, computer scientists have developed many different facial expression-centred machine learning (ML) methods for automatic infant pain assessment.
Many of these ML algorithms showed rather satisfactory performance and have demonstrated good potential to be further enhanced for implementation in real-world clinical settings.
To date, there is no prior research that has systematically summarised and compared the performance of these ML algorithms.
Our proposed meta-analysis will provide the first comprehensive evidence on this topic to guide further ML algorithm development and clinical implementation.
HO-3867 |
|
MBS384882-1mLinDMSO |
MyBiosource |
1mL(inDMSO) |
EUR 230 |
Monoclonal CD99 Antibody [Clone HO36-1.1], Clone: HO36-1.1 |
|
AMM00124G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD99 [Clone HO36-1.1]. The antibodies are raised in Mouse and are from clone HO36-1.1. This antibody is applicable in IHC, IF |
CD99(HO36-1.1), 1mg/mL |
|
BNUM0869-50 |
Biotium |
50uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD99(HO36-1.1), 0.2mg/mL |
|
BNUB0869-100 |
Biotium |
100uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD99(HO36-1.1), 0.2mg/mL |
|
BNUB0869-500 |
Biotium |
500uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD99(HO36-1.1) Antibody |
|
BNC700869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF770 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC700869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF770 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC800869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF680 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC800869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF680 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC680869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF568 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC680869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF568 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC940869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF594 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC940869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF594 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCA0869-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CD99(HO36-1.1), APC conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC610869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF660R conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC610869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF660R conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC810869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF680R conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC810869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF680R conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC880869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF488A conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC880869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF488A conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCB0869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), Biotin conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCB0869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), Biotin conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCH0869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCH0869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCP0869-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CD99(HO36-1.1), PerCP conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCR0869-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CD99(HO36-1.1), RPE conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCAP0869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNCAP0869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC430869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF543 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC430869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF543 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC050869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF405M conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC050869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF405M conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC400869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF640R conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC400869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF640R conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC470869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF647 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC470869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF647 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC550869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF555 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC550869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF555 conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC040869-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF405S conjugate, Concentration: 0.1mg/mL |
CD99(HO36-1.1) Antibody |
|
BNC040869-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD99(HO36-1.1), CF405S conjugate, Concentration: 0.1mg/mL |
Human IgG4 (pFC) mouse monoclonal antibody, clone HP6023 (also known as HO6023), AP, Purified |
|
AM01158AP-N |
Origene Technologies GmbH |
1 ml |
Ask for price |
Human IgG4 (pFC) mouse monoclonal antibody, clone HP6023 (also known as HO6023), Purified |
|
AM01158PU-N |
Origene Technologies GmbH |
500 µg |
Ask for price |
Human IgG4 (pFC) mouse monoclonal antibody, clone HP6023 (also known as HO6023), HRP, Purified |
|
AM01158HR-N |
Origene Technologies GmbH |
1 ml |
Ask for price |
MIC2 Gene Protein, CD99; Clone HO36-1.1 (Ready-To-Use) |
|
A00044-0002 |
ScyTek Laboratories |
2 ml |
EUR 33.42 |
MIC2 Gene Protein, CD99; Clone HO36-1.1 (Ready-To-Use) |
|
A00044-0007 |
ScyTek Laboratories |
7 ml |
EUR 65.57 |
MIC2 Gene Protein, CD99; Clone HO36-1.1 (Ready-To-Use) |
|
A00044-0025 |
ScyTek Laboratories |
25 ml |
EUR 200.57 |
MIC2 Gene Protein, CD99; Clone HO36-1.1 (Concentrate) |
|
A00044-C |
ScyTek Laboratories |
1 ml |
EUR 369.27 |
MIC2 Gene Protein, CD99; Clone HO36-1.1 (Concentrate) |
|
A00044-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 68.78 |
CD99 / MIC2 (Ewing's Sarcoma Marker); Clone HO36-1.1 (Concentrate) |
|
RA0203-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 60.07 |
CD99 / MIC2 (Ewing's Sarcoma Marker); Clone HO36-1.1 (Concentrate) |
|
RA0203-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 158.6 |
HO-1 monoclonal antibody (HO-1-1) |
|
MBS565088-005mg |
MyBiosource |
0.05mg |
EUR 355 |
HO-1 monoclonal antibody (HO-1-1) |
|
MBS565088-02mg |
MyBiosource |
0.2mg |
EUR 605 |
HO-1 monoclonal antibody (HO-1-1) |
|
MBS565088-1mg |
MyBiosource |
1mg |
EUR 2415 |
HO-1 monoclonal antibody (HO-1-1) |
|
MBS565088-5x1mg |
MyBiosource |
5x1mg |
EUR 10720 |
HO-1 monoclonal antibody (HO-1-2) |
|
MBS565727-1mg |
MyBiosource |
1mg |
EUR 2485 |
HO-1 monoclonal antibody (HO-1-2) |
|
MBS565727-5x1mg |
MyBiosource |
5x1mg |
EUR 11040 |
HO-1 monoclonal antibody (HO-1-1) |
|
MBS567116-005mg |
MyBiosource |
0.05mg |
EUR 380 |
HO-1 monoclonal antibody (HO-1-1) |
|
MBS567116-02mg |
MyBiosource |
0.2mg |
EUR 630 |
HO-1 monoclonal antibody (HO-1-1) |
|
MBS567116-1mg |
MyBiosource |
1mg |
EUR 2280 |
HO-1 monoclonal antibody (HO-1-2) |
|
MBS567132-02mg |
MyBiosource |
0.2mg |
EUR 665 |
HO-1 monoclonal antibody (HO-1-2) |
|
MBS567132-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2950 |
CD16(HO80), 1mg/mL |
|
BNUM1056-50 |
Biotium |
50uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), 0.2mg/mL |
|
BNUB1056-100 |
Biotium |
100uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), 0.2mg/mL |
|
BNUB1056-500 |
Biotium |
500uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Anti-CD99/ MIC2 Antibody Clone HO36-1.1, Unconjugated-100ug |
|
4267-MSM1-P1 |
EnQuireBio |
100ug |
EUR 513.6 |
Monoclonal CD99 / MIC2 (Ewing's Sarcoma Marker) Antibody, Clone: HO36-1.1 |
|
AMM01024G |
Leading Biology |
7 ml |
EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD99 / MIC2 (Ewing's Sarcoma Marker). The antibodies are raised in Mouse and are from clone HO36-1.1. This antibody is applicable in IHC, IF |
CD16(HO80) Antibody |
|
BNC701056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), CF770 conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC701056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), CF770 conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC801056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), CF680 conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC801056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), CF680 conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNCA1056-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CD16(HO80), APC conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC611056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), CF660R conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC611056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), CF660R conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC811056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), CF680R conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC811056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), CF680R conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNCP1056-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CD16(HO80), PerCP conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNCR1056-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against CD16(HO80), RPE conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNCAP1056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNCAP1056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNCH1056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNCH1056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC431056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), CF543 conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC431056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), CF543 conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC051056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), CF405M conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC051056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), CF405M conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC551056-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against CD16(HO80), CF555 conjugate, Concentration: 0.1mg/mL |
CD16(HO80) Antibody |
|
BNC551056-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against CD16(HO80), CF555 conjugate, Concentration: 0.1mg/mL |
Monoclonal CD99 / MIC2 (Ewing's Sarcoma Marker) Antibody - With BSA and Azide, Clone: HO36-1.1 |
|
AMM01025G |
Leading Biology |
0.05mg |
EUR 475.2 |
|
Description: A Monoclonal antibody against Human CD99 / MIC2 (Ewing's Sarcoma Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone HO36-1.1. This antibody is applicable in IHC, IF, FC |
HO-1 monoclonal antibody (HO-1-2) (FITC conjugate) |
|
MBS565908-005mg |
MyBiosource |
0.05mg |
EUR 330 |
HO-1 monoclonal antibody (HO-1-2) (FITC conjugate) |
|
MBS565908-02mg |
MyBiosource |
0.2mg |
EUR 590 |
HO-1 monoclonal antibody (HO-1-2) (FITC conjugate) |
|
MBS565908-5x02mg |
MyBiosource |
5x0.2mg |
EUR 2600 |
Monoclonal CD99 / MIC2 (Ewing's Sarcoma Marker) Antibody - Without BSA and Azide, Clone: HO36-1.1 |
|
AMM01026G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD99 / MIC2 (Ewing's Sarcoma Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone HO36-1.1. This antibody is applicable in IHC, IF, FC |
MCF-7 Nuclear Extract (H2O2) |
|
1642-100 |
Biovision |
each |
EUR 248.4 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (PE) |
|
MBS6158217-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (PE) |
|
MBS6158217-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (AP) |
|
MBS6131702-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (AP) |
|
MBS6131702-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
CD16(HO80), CF568 conjugate, 0.1mg/mL |
|
BNC681056-100 |
Biotium |
100uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF568 conjugate, 0.1mg/mL |
|
BNC681056-500 |
Biotium |
500uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF594 conjugate, 0.1mg/mL |
|
BNC941056-100 |
Biotium |
100uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF594 conjugate, 0.1mg/mL |
|
BNC941056-500 |
Biotium |
500uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF647 conjugate, 0.1mg/mL |
|
BNC471056-100 |
Biotium |
100uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF647 conjugate, 0.1mg/mL |
|
BNC471056-500 |
Biotium |
500uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (HRP) |
|
MBS6152914-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (HRP) |
|
MBS6152914-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) APC |
|
MBS6137005-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) APC |
|
MBS6137005-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
CD16(HO80), CF488A conjugate, 0.1mg/mL |
|
BNC881056-100 |
Biotium |
100uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF488A conjugate, 0.1mg/mL |
|
BNC881056-500 |
Biotium |
500uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), Biotin conjugate, 0.1mg/mL |
|
BNCB1056-100 |
Biotium |
100uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), Biotin conjugate, 0.1mg/mL |
|
BNCB1056-500 |
Biotium |
500uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF640R conjugate, 0.1mg/mL |
|
BNC401056-100 |
Biotium |
100uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF640R conjugate, 0.1mg/mL |
|
BNC401056-500 |
Biotium |
500uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF405S conjugate, 0.1mg/mL |
|
BNC041056-100 |
Biotium |
100uL |
EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(HO80), CF405S conjugate, 0.1mg/mL |
|
BNC041056-500 |
Biotium |
500uL |
EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (FITC) |
|
MBS6147611-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (FITC) |
|
MBS6147611-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
Hydrogen Peroxide (H2O2) Assay Kit |
|
abx294075-100g |
Abbexa |
100 µg |
Ask for price |
Hydrogen Peroxide (H2O2) Assay Kit |
|
abx294075-20g |
Abbexa |
20 µg |
EUR 225 |
Hydrogen Peroxide (H2O2) Assay Kit |
|
abx294075-50g |
Abbexa |
50 µg |
Ask for price |
Hydrogen Peroxide (H2O2) Assay Kit |
|
abx295076-100g |
Abbexa |
100 µg |
Ask for price |
Hydrogen Peroxide (H2O2) Assay Kit |
|
abx295076-20g |
Abbexa |
20 µg |
EUR 225 |
Hydrogen Peroxide (H2O2) Assay Kit |
|
abx295076-50g |
Abbexa |
50 µg |
Ask for price |
H2O2 and POD Assay Kit (Fluorometric) |
|
EGQA0074 |
EnoGene |
100 tests |
EUR 145 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (Biotin) |
|
MBS6142308-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (Biotin) |
|
MBS6142308-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 550) |
|
MBS6211915-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 550) |
|
MBS6211915-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 405) |
|
MBS6190565-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 405) |
|
MBS6190565-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 750) |
|
MBS6233265-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 750) |
|
MBS6233265-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 650) |
|
MBS6222590-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 650) |
|
MBS6222590-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 490) |
|
MBS6201240-01mL |
MyBiosource |
0.1(mL |
EUR 875 |
HMOX2 (Heme Oxygenase 2, HO-2, HO2) (MaxLight 490) |
|
MBS6201240-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3800 |
Recombinant Caenorhabditis elegans ATP synthase subunit alpha, mitochondrial (H28O16.1), partial |
|
MBS1295526-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 1285 |
Recombinant Caenorhabditis elegans ATP synthase subunit alpha, mitochondrial (H28O16.1), partial |
|
MBS1295526-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1540 |
Recombinant Caenorhabditis elegans ATP synthase subunit alpha, mitochondrial (H28O16.1), partial |
|
MBS1295526-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 1285 |
We will search four major public electronic medical and computer science databases including Web of Science, PubMed, Embase and IEEE Xplore DigitalLibrary from January 2008 to present. All the articles will be imported into the Covidence platform for study eligibility screening and inclusion.
Study-level extracted data will be stored in the Systematic Review Data Repository online platform. The primary outcome will be the prediction accuracy of the ML model.
The secondary outcomes will be model utility measures including generalisability, interpretability and computational efficiency. All extracted outcome data will be imported into RevMan V.5.2.1 software and R V3.3.2 for analysis.
Risk of bias will be summarised using the latest Prediction Model Study Risk of Bias Assessment Tool.This systematic review and meta-analysis will only use study-level data from public databases, thus formal ethical approval is not required.
The results will be disseminated in the form of an official publication in a peer-reviewed journal and/or presentation at relevant conferences.CRD42019118784.